Pancreatic Tuberculosis: Diagnostic Challenges and Management Considerations
DOI:
https://doi.org/10.52783/jns.v14.3847Keywords:
pancreatic tuberculosis, extrapulmonary TB, pancreatic masses, EUS-guided biopsy, anti-tuberculosis therapyAbstract
Background
Individuals develop pancreatic tuberculosis extremely rarely among extrapulmonary tuberculosis manifestations because doctors find it hard to diagnose because of nonspecific clinical features. The disease presents symptoms that resemble pancreatic cancers which delays the correct medical treatment. The identification of accurate diagnosis is fundamental before starting anti-tuberculosis treatment to prevent delayed medical interventions.
Methods
We reviewed pancreatic tuberculosis cases treated at a tertiary care center from January 2015 to December 2022. Medical records received combination analysis together with imaging findings and laboratory data, histopathology findings and treatment outcomes. This study aimed to analyze symptom manifestations at presentation while assessing diagnostic assessment methods and therapeutic decision-making elements besides examining ATT treatment effects on patients.
Results
Among 42 patients who fulfilled the inclusion criteria, abdominal pain and weight loss were the most prevalent presenting symptoms. Imaging studies often revealed pancreatic masses or pseudocystic changes in the head or body of the pancreas, frequently mimicking malignant lesions. Endoscopic ultrasound (EUS)-guided biopsy was the most reliable diagnostic modality, offering histopathological evidence of caseating granulomas. All patients commenced on standard ATT demonstrated significant clinical improvement, with resolution of imaging abnormalities in the majority by six months of therapy. Only two patients required surgical exploration due to complications. No mortality was directly attributed to pancreatic TB.
Conclusion
Pancreatic TB requires a high index of suspicion in patients presenting with pancreatic masses, particularly in endemic areas or immunocompromised populations. EUS-guided biopsy and histopathological confirmation are key to avoiding misdiagnosis and unnecessary interventions. Timely initiation of ATT can lead to excellent clinical outcomes. Further studies are needed to optimize diagnosis and management protocols.
Downloads
Metrics
References
Gupta R, Aman C, Singh K. Extrapulmonary TB: A Comprehensive Review of Rare Presentations. Clin Infect Dis. 2021;72(2):345–353.
Tamhane C, Gopalakrishnan G, Narayanan S. Endoscopic Ultrasound-Guided Diagnosis of Pancreatic Tuberculosis. Gastrointest Endosc. 2020;92(4):758–764.
Wang Y, Wei G, Li X. Pancreatic Tuberculosis or Pancreatic Cancer: The Diagnostic Dilemma. Pancreas. 2019;48(6):823–828.
Rai S, Thomas T, Malhotra A. Pancreatic Tuberculosis: A Critical Differential in the Management of Pancreatic Head Mass. World J Gastroenterol. 2018;24(32):3646–3652.
Shanmuganathan R, Shanthini F, Kalaivani R. Pancreatic Tuberculosis in Immunocompromised Patients. Trop Gastroenterol. 2017;38(3):179–185.
Brijwani N, Sharma S, Shenoy S. Role of Molecular Diagnostics in Extrapulmonary TB. Int J Tuberc Lung Dis. 2022;26(5):441–448.
Shah P, Munjal Y, Gupta D. Surgical vs. Medical Management of Pancreatic Tuberculosis: A Comparative Study. J Gastrointest Surg. 2021;25(8):2257–2263.
Mandal J, Mandal S. Evolving Concepts in Pancreatic Tuberculosis. Eur J Gastroenterol Hepatol. 2019;31(11):1455–1460.
World Health Organization. Global Tuberculosis Report 2020. Geneva: WHO; 2020.
Jaber O, Ezzeddine S, Kousa N. Case Series of Pancreatic Tuberculosis Presenting as Pancreatic Cysts: Diagnostic Challenges. BMC Infect Dis. 2021;21(1):612.
Chang Q, Chen Z, Pan Y. Autoimmune Pancreatitis vs Pancreatic Tuberculosis: Key Diagnostic Insights. Clin Gastroenterol Hepatol. 2022;20(10):2271–2277.
Balthazar E, Freeny P. Imaging of Pancreatic Diseases: Cancer vs. Inflammatory Causes. Radiol Clin North Am. 2019;57(1):63–79.
Bhatia A, Tandon R, Kumar A. EUS-Guided FNA for Suspected Pancreatic Tuberculosis: Feasibility and Accuracy. Endosc Ultrasound. 2020;9(3):179–185.
Arvanitakis M, Dumonceau J. Surgical Indications in Pancreatic Pseudocysts and Tuberculosis. Dig Surg. 2018;35(2):143–150.
Liu R, Chen C. Future Perspectives in Pancreatic Tuberculosis Diagnosis: Role of Molecular Diagnostics. J Clin Med. 2023;12(5):1920.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.